Advanced Oncotherapy (AVO)

 

AVO Share PerformanceMore

52 week high209.875 27/05/16
52 week low23.875 09/03/17
52 week change -145.625 (-84.73%)
4 week volume6,851,245 28/03/17

Media for (AVO)

Presenter: Donatella Ungaro
15/12/2016
Presenter: Nicolas Serandour
13/10/2016

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Conversion of loan notes

RNS Number: 4864C Advanced Oncotherapy PLC 18 April 2017 18 April 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Conversion of Convertible Loan Notes Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Bracknor Investment Group ("B...

Director Deals - Advanced Oncotherapy PLC (AVO)

Dr Enrico Vanni, Non Executive Director, bought 100,000 shares in the company on the 12th April 2017 at a price of 27.50p...

Director Dealing

RNS Number: 3826C Advanced Oncotherapy PLC 13 April 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Director Dealing Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that yesterday, Dr Enrico Vanni purchased 100,000 Ordinary Shares of 2...

Conversion of loan notes

RNS Number: 1103C Advanced Oncotherapy PLC 11 April 2017 11 April 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Conversion of Convertible Loan Notes Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Bracknor Investment Group ("Br...

Advanced Oncotherapy loan note conversion

Advanced Oncotherapy has issued 369,307 new ordinary shares following the conversion of loan notes by Bracknor Investm...

Conversion of loan notes

RNS Number: 8637B Advanced Oncotherapy PLC 07 April 2017 7 April 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Conversion of Convertible Loan Notes Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Bracknor Investment Group ("B...

Total Voting Rights

RNS Number: 8320B Advanced Oncotherapy PLC 06 April 2017 6 April 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Total Voting Rights Further to the announcement of 7 November 2016, Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that ...

Director Deals - Advanced Oncotherapy PLC (AVO)

Dr Enrico Vanni, Non Executive Director, bought 25,000 shares in the company on the 4th April 2017 at a price of 29.25p. ...

Fundamental DataMore

EPS-0.51
Dividend yield0 %

Equity Research (AVO)

hardman & co
Advanced Oncotherapy Plc
15/03/2017
AVO is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world renowned CERN. The company is entering an exciting stage...
Advanced Oncotherapy Plc
27/02/2017
PowerHouse Energy Group (PHE.L) 1p £8.94m PowerHouse has agreed with University of Chester to deploy its G3-UHt unit (ultra-high temperature demonstration gasification system)  at its Thornton...
hardman & co
Advanced Oncotherapy Plc
02/11/2016
AVO is focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN. Planning Permission for its...

Latest discussion posts More

  • Re: Pretty Impressive

    The market knows that there is a very material overhang from the avalanche of shares that are due to be issued under the Bracknor death spiral convertible of which another ...
    7-Apr-2017
    JakNife
  • Pretty Impressive

    That is a healthy quick 10% increase on buy vs sell price. And all because of just a few trades totaling less than #50k Anyone would think the market has walked this down ...
    6-Apr-2017
    Disorder
  • Re: director buying

    SP reflecting a bias towards sellers than buyers. Can sell 100k online, but can only purchase 10k. Interest will see a marked increase in sp. We see it all to often. ...
    6-Apr-2017
    Disorder

Users' HoldingsMore

Users who hold Advanced Oncotherapy also hold..
LLOYDS GRP.22%
SIRIUS MINERALS16%
ROYAL BANK SCOT12%
BP12%
BT GROUP11%

Codes & Symbols

ISINGB00BD6SX109
SymbolsAVO, LSE:AVO, AVO.L, AVO:LN, LON:AVO, XLON:AVO